Detection of blood-vessel wall artifacts

• US 9,492,090 B2
• Filed: 10/05/2011
• Issued: 11/15/2016
• Est. Priority Date: 10/08/2010
• Status: Active Grant

• Current Assignee: Edwards Lifesciences Corporation
• Original Assignee: Edwards Lifesciences Corporation
• Inventors: Young, Clayton M., Jian, Zhongping, Hatib, Feras
• Primary Examiner(s): Cattungal, Sanjay
• Application Number:
  US13/878,411
• Publication Number:
  US 20130324840A1
• Time in Patent Office: 1,868 Days
• Field of Search: 600473-480
• US Class Current: 1/1
• CPC Class Codes: A61B 5/0084 for introduction into the body, e.g. by catheters A61B5/1459 takes precedence
• CPC Class Codes: A61B 5/027 using catheters
• CPC Class Codes: A61B 5/065 Determining position of the probe employing exclusively positioning means located on or in the probe, e.g. using position sensors arranged on the probe
• CPC Class Codes: A61B 5/1459 invasive, e.g. introduced into the body by a catheter A61B5/1464 takes precedence
• CPC Class Codes: A61B 5/6852 Catheters
• CPC Class Codes: A61B 5/6886 Monitoring or controlling distance between sensor and tissue
• CPC Class Codes: A61B 5/7203 for noise prevention, reduction or removal
• CPC Class Codes: A61B 5/7221 Determining signal validity, reliability or quality A61B5/7207 and A61B5/7217 take precedence
• CPC Class Codes: A61B 5/7405 using sound
• CPC Class Codes: A61B 5/742 using visual displays A61B5/339 takes precedence
• CPC Class Codes: A61M 25/01 Introducing, guiding, advancing, emplacing or holding catheters A61M25/10 takes precedence

Abstract

The present application concerns detecting catheter proximity to a blood-vessel wall and blood-vessel wall artifacts associated therewith. In one embodiment, a light source, in a catheter, can be used to project light into the blood vessel. An intensity associated with at least one light wavelength that interacted with blood can be measured. Based on the measured intensity, a determination can be made regarding blood-vessel wall artifacts due to the catheter tip proximity to a blood-vessel wall. Feedback can be provided to the clinician in order to assist the clinician in adjusting the catheter to optimize signal quality and minimize artifacts due to the blood-vessel wall.

Claims

1. A method comprising:

projecting a light from a catheter into a blood vessel having a blood-vessel wall;

measuring a first intensity of a first wavelength associated with the light;

measuring a second intensity of a second wavelength associated with the light;

calculating a ratio of the first intensity and the second intensity;

comparing the ratio with a threshold; and

based on the comparing, determining a proximity of the catheter to the blood-vessel wall;

wherein the first wavelength is below approximately 580 nm and the second wavelength is above approximately 720 nm.

2. The method of claim 1, wherein if the ratio exceeds the threshold, outputting an indicator to indicate that the catheter is too close to the blood-vessel wall.

3. The method of claim 1, further including filtering the first wavelength to attenuate background and random noise prior to measuring the first intensity.

4. The method of claim 1, wherein the catheter includes a transmit optical fiber and a receive optical fiber.

5. The method of claim 1, wherein measuring the first intensity includes receiving the first wavelength from a receive optical fiber and using a photodetector to capture electromagnetic energy associated therewith.

6. A non-transitory computer storage medium having a computer program product stored thereon, the computer program product comprising instuctions which, when executed on at least one processor, cause the at least one processor to implement the method of claim 1.

7. The method of claim 2, wherein the indicator includes outputting a visual or audio signal to a clinician.

8. The method of claim 1, wherein projecting the light is through a transmit optical fiber in the catheter during catherization, and wherein the method further includes receiving the light after the light interacts with a blood in the blood vessel through a receive optical fiber.

9. The method of claim 8, wherein interaction of the light with the blood includes transmission, reflection and scattering of light waves.

10. The method of claim 1, wherein measuring the first intensity is performed using photodetectors.

11. The method of claim 7 further comprising:

dynamically and interactively modifying the visual or audio output signal to the clinician, as the clinician moves the catheter.

12. The method of claim 1, wherein the first wavelength is above approximately 400 nm and the second wavelength is below approximately 850 nm.

13. An apparatus comprising:

a catheter including a transmit optical fiber and a receive optical fiber;

a light source coupled to the transmit optical fiber for transmitting a light into a blood vessel having a blood and a blood-vessel wall;

one or more photodetectors coupled to the receive optical fiber for receiving the light after the light interacts with the blood; and

a controller coupled to the one or more photodetectors and configured to;

measure a first intensity of a first wavelength associated with the light;

measure a second intensity of a second wavelength associated with the light;

calculate a ratio of the first intensity and the second intensity;

compare the ratio with a threshold; and

based on comparing, determine a proximity of the catheter to the blood-vessel wall;

wherein the first wavelength is below approximately 580 nm and the second wavelength is above approximately 720 nm.

14. The apparatus of claim 13, wherein the light source includes one or more LEDs.

15. The apparatus of claim 13, further including an output device coupled to the controller for providing a visual or audio signal to a clinician based on the proximity.

16. The apparatus of claim 13, wherein the controller dynamically and interactively modifies a visual or audio output signal indicative of the proximity of the catheter to the blood-vessel wall, as a clinician moves the catheter.

17. The apparatus of claim 13, wherein the first wavelength is above approximately 400 nm and the second wavelength is below approximately 850 nm.